Nonsteroidal anti-inflammatory drugs
PreclinicalSmall molecule
Nonsteroidal anti-inflammatory drugs is one of 24 small molecule programs targeting Stricture. It is currently in Preclinical.
2
Indications
3
Total Trials
1
Active Trials
23
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
15 competitors in Frozen Shoulder
#DrugCompanyPhaseTrials
1Medrol
PfizerApproved
Elavil
AstraZenecaApproved
Xylocaine
MMEDRx USA, Inc.
Approved
Decadron
AAspen Global Incorporated
Approved
Aspercreme Warming
AAveritas Pharma, Inc.
Approved
Deltasone
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Rayos
RRoxane Laboratories
Approved
Avastin
RochePhase 2
Compound Betamethasone
SSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 3
Bayer Aspirin
BayerPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Frozen Shoulder1 trial
Effects of App-assisted Home Exercise Program in Patients With Frozen Shoulder
Completed·—·N/A·NCT05980572·21 enrolled
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- SStanford University